MedTrace Logo

Respiratory Rate Validation Study - RS001.2 Respiree Cardio-Respiratory Monitor

NCT05210712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-05-02

No results posted yet for this study

Summary

The purpose of this study is to conduct a Respiratory Rate accuracy validation comparing the RS001.2 Respiree Cardio-Respiratory Monitor to the Reference, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda).

Conditions

  • A Minimum of 30 Adults, Ages 18 Years and Older

Interventions

DEVICE

RS001.2 Respiree Cardio-Respiratory Monitor

The RS001.2 Respiree Cardio-Respiratory Monitor is intended as a noninvasive multiparameter monitor on the adult population

Sponsors & Collaborators

  • Respiree Pte Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-24
Primary Completion
2022-02-10
Completion
2022-02-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05210712 on ClinicalTrials.gov